Condition
Hard to Heal Wounds
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
Early P 1 (1)
P 2 (1)
Trial Status
Completed2
Not Yet Recruiting1
Unknown1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07747896Not ApplicableRecruiting
Effect of a Coordinated Primary-care-Based MDT-model on the Treatment of Hard-to-heal Ulcers
NCT07235254Not ApplicableNot Yet Recruiting
A RCT of Moist Ag Dressing in Chronic Wound
NCT07050667Not ApplicableCompletedPrimary
Treatment of Chronic Wounds With Cold Plasma -Plasma Care® vs. Placebo
NCT02020746Phase 2CompletedPrimary
Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds
NCT01772303Early Phase 1UnknownPrimary
Safety and Efficacy Study of HO/03/03 10-40 Micro Grams to Treat Hard to Heal Wounds
Showing all 5 trials